Research location
Faenza
Italy
Advertisement
Research activity in Faenza
ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 17 trials and 17 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Faenza
17 linked trials · page 1 of 1A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTENCT05171075 · 2022-09-27 · 1 site observation
TERMINATED
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTENCT05171049 · 2022-05-05 · 1 site observation
TERMINATED
Effects of COVID-19 Pandemic on the Outcomes of Colorectal CancerNCT04712292 · 2020-09-08 · 1 site observation
UNKNOWN
Adjuvant Palbociclib in Elderly Patients With Breast CancerNCT03609047 · 2019-06-14 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate CancerNCT03748641 · 2019-01-25 · 1 site observation
ACTIVE_NOT_RECRUITING
Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast CancerNCT03595592 · 2018-09-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer PatientsNCT05833919 · 2018-07-30 · 1 site observation
UNKNOWN
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsNCT03485209 · 2018-06-25 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyNCT02975934 · 2017-06-13 · 1 site observation
COMPLETED
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyNCT02952534 · 2017-02-15 · 1 site observation
COMPLETED
Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung CancerNCT02633189 · 2016-04-01 · 1 site observation
UNKNOWN
Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast CancerNCT02404051 · 2015-12-01 · 1 site observation
UNKNOWN
Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC PatientsNCT02383030 · 2015-11-01 · 1 site observation
UNKNOWN
Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)NCT02134015 · 2014-03-01 · 1 site observation
TERMINATED
MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung CancerNCT01656551 · 2012-08-01 · 1 site observation
UNKNOWN
MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung CancerNCT01405586 · 2011-03-01 · 1 site observation
UNKNOWN
Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLINNCT00831909 · 2009-01-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.